אדקס פורטה 400

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ixtrih issa

Ingredjent attiv:

IBUPROFEN

Disponibbli minn:

DEXCEL LTD, ISRAEL

Kodiċi ATC:

M01AE01

Għamla farmaċewtika:

קפליות

Kompożizzjoni:

IBUPROFEN 400 MG

Rotta amministrattiva:

פומי

Tip ta 'preskrizzjoni:

אין צורך במרשם

Manifatturat minn:

DEXCEL LTD, ISRAEL

Grupp terapewtiku:

IBUPROFEN

Żona terapewtika:

IBUPROFEN

Indikazzjonijiet terapewtiċi:

For the relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. For the relief of mild to moderate pain and treatment of primary dysmenorrhea.For the treatment of pain associated with migraine.

Data ta 'l-awtorizzazzjoni:

2013-03-31

Fuljett ta 'informazzjoni

                                " )
(
-
1986
®
200 /
®
400 ,
200
(
Ibuprofen
)
200
."
400
(
Ibuprofen
)
400
."
-
6
"
"
2
"
"
.
.
.
.
,
,
12
.
.
3
"
?
"
.
.
,
)
(
10
3
(
12-18
)
.
1
.
?
200 /
400
;
,
,
,
,
:
.)
(
200
. :
(
NSAIDs
)
.
.
,
2
.
:

)
(
,)
(
(
6
)
(
NSAIDs
)
.

-
NSAIDs
.

(
2
)
.

(
,
,
,]
[
)
,
(
-
NSAIDs
.)

12
.

.

"
(
,
.)"
:
200 /
400
: ,

.

.

,
,
,
,
(
)
,
"
(
-
"
–
"
TIA
"
.)

(
.)

,
,
.
2

.
,

(
)
.

65
,
.

.

(
Varicella
.)

,
,
.
.
,
.
,
.

.
.
:

/
,
,
,
.
.

.
,
,
,
,
.
4
.
:
, ,
.
:

NSAIDs
:
(
COX-2
[
COX-2 inhibitors
)]

(
)
.

.

(
SSRIs
,)
.

,
NSAIDs
.

(
)
.

)
(
.

.)
(

.)
(

(
.)

.
)
(

:
HIV(+)
.

(
)
–
NSAIDs
.

(
,
)
,
.

:
(
,)
ACE
(
)
II
(
)
.

.)
( .
.
3
.
: ,

.
.
.
.
,

20
.
-
NSAIDs
20
.

-
6
.
-
3
.

-
.
,
.
.
.
-
1
(
23
) "
,
."
"
3
.
?
. :
12
:
200
:
1-2
,
3
.
4
.
-
6
-
24
.
400
:
3
.
4
.
-
3
-
24
.
12
.
.
(
12-18
)
–
-
3
.
–
-
10
.
,
.
,
)
(
,
)
(
.
–
(
2
.)
:
.
.
.
,
,
.
,
,
,)
(
,
,
.
,
, ,
,)
(
,
4
.
,
,
,
.
.
!
.
. ,
.
4
.
,
200 /
400
.
.
.
:

(
/
)

:
,
-
'
.

DRESS
(
.)
DRESS
,
,
:
.)
(

,
,
(
,
,
,
AGEP
.)
.
2
. :

,
,
.
,
,
,

.
)
(

.

.

,
,
,
.

.
,
,
,
,
,

,
,
,
.)
(
,
,

.
,

.
,
,
,)
(
,

(
–
.)

(
Varicella
.)

.
.

200 /
400
.
)
(

.

.
)
'
(
NSAIDs
.
.
,
,
NSAIDs
5
.
,
.
. ,
,
.
"
(
"
www.health.gov.il
)
,
:
https://sideeffects.health.gov.il/
5
.
?

!
/
.
.

.
.

:
,
-
°C
25
.

.
.
,
6
.
:
200
:
Microcrystalline cellulose, maize starch, croscarmellose sodium,
magnesium
stearate, hypromellose, carmellose sodium, silica colloidal anhydrous,
talc, stearic
acid, titanium dioxide (E-171), erythrosine aluminium lake (E-127),
macrogol 400,
carnauba wax, quinoline yellow aluminium lake (E-104), brilliant blue
FCF aluminium
lake E-133.
400
:
Microcrystalline cellulose, maize starch, croscarmellose sodium,
magnesium
stearate, carmellose sodium, silica colloidal anhydrous, hypromel
                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ingliż 16-10-2018
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Ingliż 16-10-2018
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Għarbi 16-10-2018

Fittex twissijiet relatati ma 'dan il-prodott